The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis

被引：0
作者：
Yanxia He
Yan Gao
Liqin Ping
Haixia He
Cheng Huang
Bing Bai
Xiaoxiao Wang
Zhiming Li
Qingqing Cai
Yuhua Huang
Xueyi Pan
Wenbin Zeng
Yanan Liu
Huiqiang Huang
机构：
[1] Sun Yat-Sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine
[2] Sun Yat-Sen University Cancer Center,Department of Medical Oncology
[3] Sun Yat-Sen Memorial Hospital,Department of Radiation Oncology
[4] Sun Yat-Sen University,Department of Pathology
[5] Sun Yat-Sen University Cancer Center,Department of Hematology
[6] The First Affiliated Hospital of Guangdong Pharmaceutical University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Hemophagocytic lymphohistiocytosis; Extranodal NK/T-cell lymphoma; Anti-PD-1 antibody; Epstein–Barr virus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2017 / 2027
页数：10
相关论文
共 23 条
  • [21] The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type
    Liang, Li
    Nong, Lin
    Zhang, Shuang
    Zhao, Jing
    Ti, Hongjuan
    Dong, Ying
    Zhang, Bo
    Li, Ting
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
  • [22] A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens
    Wu, Wanchun
    Ren, Kexin
    Chen, Xi
    Li, Na
    Zhou, Huijie
    Jiang, Ming
    Yu, Youhui
    Zou, Liqun
    CANCER MEDICINE, 2023, 12 (08): : 9439 - 9448
  • [23] Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics
    Wang, Yao
    Zhang, Minan
    Xue, Qingfeng
    Zhou, Huan
    Chen, Jie
    Wang, Hong
    Zhang, Yaping
    Shi, Wenyu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
123